Meet the Speakers of 2020

Conference Co-Chairpersons

Ruti Alon

Founder & CEO

Medstrada

Nissim Darvish, MD, PhD

Senior Managing Director

OrbiMed

Ora Dar, PhD

Senior Expert

Medical Sciences & Health Innovation

Plenary Speakers

Robert Cohen

VP of Global R&D, Chief Technology Officer

Stryker Joint Replacement

Amy Schulman

Managing Partner

Polaris Partners

Prof. Robert Langer

Institute Professor at MIT

MIT Department of Chemical Engineering

Andrew “Cal” Callaway

Managing Director, U.S. Healthcare Investment Banking

Royal Bank of Canada (RBC)

Prof. Yitshak Kreiss, MD

Director General

Sheba Medical Center

Maurice R. Ferré, MD

CEO and Chairman of the Board

INSIGHTEC

Jeremy M. Levin, MD

CEO and Chairman

Ovid Therapeutics

Eric H. Rubin, MD

Senior VP, Global Clinical Oncology

Merck & Co

Aharon Aharon

CEO

Israel Innovation Authority (IIA)

Amir Gross

Ex-CEO

Valtech

Ori Hadomi

Ex-CEO

Mazor Robotics

Prof. Raphael Beyar, MD, PhD

Co-Founder

Corindus

Oded S. Lieberman, PhD, MBA

CEO

NeuroDerm

Asaf Danziger

CEO

Novocure

Delos M. Cosgrove, MD

Executive Advisor to Google; Former President & CEO

Cleveland Clinic

Targeted Cancer Treatment; Cure? Maintenance? – Has Medicine Reached these Points?

Prof. David Sidransky, MD
(Track Chair)

Co-Founder & General Partner

Israel Biotech Fund

Decoding the Brain Enigma: Parkinson, Alzheimer’s ALS, Mental Disorders

Barry Greene
(Track Co-Chair)

President

Alnylam Pharmaceuticals

Dekel Taliaz, PhD
(Track Co-Chair)

Co-Founder and CEO

Taliaz

Jeremy M. Levin, MD

CEO and Chairman

Ovid Therapeutics

Allitia DiBernardo, MD

Global Medical Affairs Lead, Neurosciences

The Janssen Pharmaceutical Companies of Johnson & Johnson

Andre Machado, MD, PhD

Neurological Institute, Chairman; Functional Neurosurgery, Endowed Chair

Cleveland Clinic

Dimitrios Arkilo, MD

Sr. Medical Director, Global Clinical Lead

Takeda Pharmaceutical Co

AI Technology Redefining the Future of Biopharma, Care Delivery, and Holistic Medicine

Iris Grossman, PhD
(Track Co-Chair)

Chief Scientific Officer

CAMP4 Therapeutics

Tamara Mansfeld
(Track Co-Chair)

Global Innovation Lead, Digital Innovation Lab

Pfizer

Federico Goodsaid, PhD

Ex-FDA & Senior VP Regulatory Affairs

Ariana Pharma

Dimitris Agrafiotis, PhD, FRSC

Chief Information Officer

Novartis Institutes for BioMedical Research (NIBR)

Rosana Kapeller-Libermann, PhD

EIR

Google Ventures

Daphna Laifenfeld, PhD

Chief Strategy Officer

Ibex Medical Analytics

Michal Ozery-Flato, PhD

Machine Learning Researcher

IBM Research

Next Generation BioTherapeutics – Gene Editing, RNAi, Oligos, Cell and Gene Therapies and others

Yaron Carmi, PhD
(Track Co-Chair)

Assistant Professor, Sackler School of Medicine

Tel Aviv University

Jonathan Solomon
(Track Co-Chair)

CEO

Biomx

Barry Greene

President

Alnylam Pharmaceuticals

Pierre Belichard

CEO

Enterome

Eric de La Fortelle, PhD

Venture Partner

Seventure

Bright Spots Illuminating the Future of Medical Devices

Irit Yaniv, MD
(Track Co-Chair)

Managing Partner

Accelmed Ventures Fund

James Eadie, MD
(Track Co-Chair)

Partner

Santé Ventures

Exact and Biological Science Diagnostics – Sensors, Genomics, AI, Imaging, and others

Prof. Varda Shalev, MD, MPA
(Track Co-Chair)

Head

KSM Kahn - Sagol - Maccabi Research & Innovation Institute

Yair Schindel, MD
(Track Co-Chair)

Managing Partner & Co-Founder

aMoon Fund

Tom Sudow

Director Business Development

Cleveland Clinic Innovations

Miro Venturi, PhD

Global Head - Diagnostics Biomarkers

F. Hoffmann-La Roche Ltd.

Prof. Peter A. Noseworthy, MD

Department of Cardiovascular Medicine

Mayo Clinic

Robotics Role in Future Healthcare Systems

Ori Hadomi
(Track Chair)

VP New Business Development & Partnerships

Medtronic

Wenbo Liu

Sinovation (Beijing) Medical Technology Co., LTD

Prof. Tamar Flash, PhD

Department of Computer Science and Applied Mathematics

Weizmann Institute of Science

Prof. Amir Lerman, MD

Cardiovascular Diseases and Internal Medicine

Mayo Clinic

Aging Science and Technology – From Single Cell to Population at Large

Anat Naschitz
(Track Co-Chair)

Managing Director

OrbiMed Advisors

Yael Benvenisti, PhD
(Track Co-Chair)

CEO

Mediterranean Towers Ventures